KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Medpace Holdings (MEDP) over the last 11 years, with Q3 2025 value amounting to -$87000.0.

  • Medpace Holdings' Gains from Investment Securities fell 7058.82% to -$87000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $92.2 million, marking a year-over-year increase of 3353.47%. This contributed to the annual value of $83.6 million for FY2024, which is 944.82% up from last year.
  • According to the latest figures from Q3 2025, Medpace Holdings' Gains from Investment Securities is -$87000.0, which was down 7058.82% from $18000.0 recorded in Q2 2025.
  • Over the past 5 years, Medpace Holdings' Gains from Investment Securities peaked at $91.7 million during Q4 2024, and registered a low of -$8.0 million during Q1 2024.
  • Its 5-year average for Gains from Investment Securities is $14.3 million, with a median of $1.5 million in 2023.
  • In the last 5 years, Medpace Holdings' Gains from Investment Securities soared by 300829.55% in 2021 and then plummeted by 2160000.0% in 2023.
  • Over the past 5 years, Medpace Holdings' Gains from Investment Securities (Quarter) stood at $53.2 million in 2021, then fell by 9.17% to $48.3 million in 2022, then soared by 59.85% to $77.2 million in 2023, then rose by 18.86% to $91.7 million in 2024, then plummeted by 100.09% to -$87000.0 in 2025.
  • Its last three reported values are -$87000.0 in Q3 2025, $18000.0 for Q2 2025, and $502000.0 during Q1 2025.